Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradip De

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|July 14, 2023
Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Cancers|October 14, 2022
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Cancer Research|June 24, 2017
Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown PrimaryShumei Kato, Nithya Krishnamurthy, Kimberly C Banks, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2013
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivoPradip De, Nandini Dey, Breanne Terakedis, et al.
Cancer Medicine|May 3, 2023
LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeuticsJacob J Adashek, Shumei Kato, Daisuke Nishizaki, et al.
Cancer Research|January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activityJoseph R Garlich, Pradip De, Nandini Dey, et al.
Cancers|June 24, 2022
A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-ImmunofluorescenceRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
BMC Cancer|November 12, 2013
Wnt signaling in triple negative breast cancer is associated with metastasisNandini Dey, Benjamin G Barwick, Carlos S Moreno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteinsYu Li, Jingliang Yan, Pradip De, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|July 14, 2023
Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Cancers|October 14, 2022
Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Cancer Research|June 24, 2017
Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown PrimaryShumei Kato, Nithya Krishnamurthy, Kimberly C Banks, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2013
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivoPradip De, Nandini Dey, Breanne Terakedis, et al.
Cancer Medicine|May 3, 2023
LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeuticsJacob J Adashek, Shumei Kato, Daisuke Nishizaki, et al.
Cancer Research|January 4, 2008
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activityJoseph R Garlich, Pradip De, Nandini Dey, et al.
Cancers|June 24, 2022
A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-ImmunofluorescenceRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
BMC Cancer|November 12, 2013
Wnt signaling in triple negative breast cancer is associated with metastasisNandini Dey, Benjamin G Barwick, Carlos S Moreno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteinsYu Li, Jingliang Yan, Pradip De, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Pageof 7